Contraindications | Risperdal Consta

Contraindications

Risperdal® Consta® must not be given in cases of hyperprolactinaemia, i.e. when there are elevated levels of the hormone prolactin in the blood. This excess of prolactin can be caused by a tumor of the pituitary gland (so-called prolactinoma). Particular caution is advised when taking Risperdal® Consta® in patients with Parkinson’s disease and severe cardiovascular diseases. These diseases could worsen under Risperdal® Consta® therapy. The indication for Risperdal® Consta® therapy must also be checked separately for liver and kidney dysfunctions.

Use in children and elderly patients

Risperdal® Consta® is not approved for use in children and adolescents under 18 years of age or older patients with dementia. In older patients with dementia, an increased incidence of strokes and increased mortality has been observed when treated with Risperdal® Consta®.

Use during pregnancy/breastfeeding

Risperdal® Consta® should not be used during pregnancy or while breastfeeding. The fact that the drug increases the level of the hormone prolactin in the blood can impair fertility and fertility.

Roadworthiness

Risperdal® Consta® can cause fatigue, dizziness and visual disturbances. The ability to participate in road traffic and to operate machinery should be clarified with the attending physician.

Side effects

Various side effects can occur when using Risperdal® Consta®. Symptoms similar to Parkinson’s disease (so-called Parkinsonism) have been observed particularly frequently. Those affected suffer from movement difficulties and walking disorders (small, tripping steps), muscle stiffness and increased saliva production. Headaches, gastrointestinal complaints, sleep disorders, weight gain, dizziness and sexual dysfunction are also common. In addition, there is always the risk of an inflammation of the injection site in the case of an intramuscular injection.

Notes

Since Risperdal® Consta® is administered to the patient by medical personnel, it is essential that the two-week injection dates are observed. If the appointment cannot be kept, an alternative appointment should be made as soon as possible, as omitting an injection can lead to worsening symptoms and numerous side effects.